IFP Advisors, Inc - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 240 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2023. The put-call ratio across all filers is 1.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
IFP Advisors, Inc ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q3 2023$2,602
-69.6%
73
-50.0%
0.00%
Q2 2023$8,546
+65.0%
146
+100.0%
0.00%
Q1 2023$5,179
+32268.8%
73
-68.0%
0.00%
Q4 2022$16
-99.8%
228
+60.6%
0.00%
Q3 2022$10,0000.0%1420.0%0.00%
Q2 2022$10,0000.0%1420.0%0.00%
Q1 2022$10,000142
+3450.0%
0.00%
Q2 2021$0
-100.0%
4
-71.4%
0.00%
Q1 2021$2,000
-50.0%
14
-56.2%
0.00%
Q4 2020$4,000
+300.0%
32
+220.0%
0.00%
Q3 2020$1,000100.00%
Q2 2020$000.00%
Q1 2020$000.00%
Q4 2019$000.00%
Q3 2019$0
-100.0%
0
-100.0%
0.00%
Q3 2018$1,0000.0%140.0%0.00%
Q2 2018$1,00014
+250.0%
0.00%
Q3 2017$040.0%0.00%
Q2 2017$040.0%0.00%
Q1 2017$040.0%0.00%
Q4 2016$040.0%0.00%
Q3 2016$040.0%0.00%
Q2 2016$0
-100.0%
4
-63.6%
0.00%
Q4 2015$1,000110.00%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q2 2023
NameSharesValueWeighting ↓
First Light Asset Management, LLC 437,512$31,772,0002.80%
RTW INVESTMENTS, LP 1,373,284$99,728,0002.06%
Rock Springs Capital Management LP 1,028,109$74,661,0001.88%
Privium Fund Management B.V. 112,727$8,186,0001.81%
Avidity Partners Management LP 869,000$63,107,0001.31%
SUVRETTA CAPITAL MANAGEMENT, LLC 525,100$38,133,0001.16%
Boxer Capital, LLC 200,000$14,524,0000.75%
SECTOR GAMMA AS 46,221$3,357,0000.73%
FEDERATED HERMES, INC. 3,987,728$289,589,0000.65%
EMERALD ADVISERS, LLC 223,952$16,263,0000.62%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders